Palonosetron Prevents Highly Emetogenic Chemotherapy-induced Nausea and Vomiting in Oral Cancer Patients.
Sento S, Kitamura N, Yamamoto T, Nakashiro K, Hamakawa H, Ibaragi S, Sasaki A, Takamaru N, Miyamoto Y, Kodani I, Ryoke K, Mishima K, Ueyama Y; ORAL CANCER STUDY GROUP OF CHUGOKU-SHIKOKU.
Sento S, et al. Among authors: kitamura n.
Anticancer Res. 2017 Dec;37(12):6977-6981. doi: 10.21873/anticanres.12165.
Anticancer Res. 2017.
PMID: 29187483
Clinical Trial.